You are here

AstraZeneca

Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet

Fierce Pharma

Wed, 02/19/25 - 10:42 am

executive compensation

Pending US Vaccine Decisions as Kennedy Takes Top Health Job

US News and World Report

Fri, 02/14/25 - 09:25 am

Robert F Kennedy Jr.

Bavarian Nordic

AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial

Clinical Trials Arena

Fri, 02/7/25 - 11:24 am

clinical trials

Parkinson's Disease

AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance

Investors Business Daily

Thu, 02/6/25 - 11:51 am

Pressure relieved on AZ as details of Chinese probe emerge

Pharmaphorum

Thu, 02/6/25 - 11:32 am

AstraZeneca shareholders say they need clarity on China investigations

MSN/Reuters

Wed, 02/5/25 - 10:46 pm

Report says AZ's UK plant decision is not just about funding

Pharmaphorum

Mon, 02/3/25 - 11:42 am

drug manufacturing

AstraZeneca abandons plan for £450m vaccine plant in UK

Pharmaphorum

Fri, 01/31/25 - 11:07 am

drug manufacturing

Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer

BioPharma Dive

Tue, 01/28/25 - 10:40 am

HER2-low breast cancer

AstraZeneca invests $570M to grow in Canada, plans to add 700 jobs

Fierce Biotech

Thu, 01/23/25 - 11:10 pm

Calquence Combo Therapy Approved for Previously Untreated Mantle Cell Lymphoma

Hematology Advisor

Wed, 01/22/25 - 07:19 pm

mantle cell lymphoma

AstraZeneca overhauls management of its scandal-hit China division

Financial Times

Fri, 01/17/25 - 11:22 am

AstraZeneca gets full FDA approval for CMS-selected lymphoma treatment

BioSpace

Fri, 01/17/25 - 11:15 am

mantle cell lymphoma

J&J says its lung cancer drug combination keeps people alive longer

CNBC

Tue, 01/7/25 - 11:13 am

clinical trials

2025 forecast: What can AstraZeneca's China probes teach other biopharma companies?

Fierce Pharma

Mon, 12/30/24 - 10:48 pm

Lynparza boosts long-term survival in early breast cancer

Pharmaphorum

Thu, 12/12/24 - 11:29 am

ASH 2024: AstraZeneca set to take a BiTE out of follicular lymphoma market

Clinical Trials Arena

Mon, 12/9/24 - 11:12 am

follicular lymphoma

ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia

Fierce Pharma

Sun, 12/8/24 - 09:53 pm

chronic lymphocytic leukemia

AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval

Fierce Biotech

Fri, 12/6/24 - 09:51 am

FDA clears AZ's Imfinzi for aggressive lung cancer

Pharmaphorum

Thu, 12/5/24 - 11:10 am

small cell lung cancer

Pages